kabutan

STELLA PHARMA CORPORATION, First Half Ordinary Profit Loss Narrows, July-September Ordinary Profit Loss Narrows

Fri Nov 8, 2024 2:00 pm JST Earnings

4888 STELLA PHARMA CORPORATION 【J-GAAP】

Earnings Report

STELLA PHARMA CORPORATION <4888> [TSE-G] announced its financial results in the afternoon session on November 8th (14:00). The ordinary loss (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2025 (April to September) was a reduced loss of 267 million yen (compared to a loss of 303 million yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit/loss for the October to March period (second half) is expected to turn into a profit of 10 million yen (compared to a loss of 457 million yen in the same period last year).

In the most recent three-month period, from July to September (2Q), the ordinary loss improved to a deficit of loss of 106 million yen (compared to a loss of 139 million yen in the same period last year). The operating profit/loss margin improved from -150.0% in the same period last year to -95.4%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 92 -366 -342 -344 -12.0 ー Nov 9, 2022 J-GAAP
Apr - Sep, 2023 153 -301 -303 -305 -10.0 ー Nov 9, 2023 J-GAAP
Apr - Sep, 2024 169 -269 -267 -268 -8.2 ー Nov 8, 2024 J-GAAP
YoY +10.5% +10.6% +11.9% +12.1% +17.5%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance ー ー ー ー － 0 May 10, 2024 J-GAAP
Apr - Sep, 2024 Results 169 -269 -267 -268 -8.2 0 Nov 8, 2024 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 116 -459 -457 -458 -14.8 0 May 10, 2024 J-GAAP
Oct - Mar, 2024 Guidance 761 17 10 8 0.2 0 Nov 8, 2024 J-GAAP
YoY +556.0% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 229 -806 -775 -778 -27.0 0 May 9, 2023 J-GAAP
Mar, 2024 269 -760 -760 -763 -24.7 0 May 10, 2024 J-GAAP
Mar, 2025 Guidance 930 -252 -257 -260 -7.6 0 May 10, 2024 J-GAAP
YoY +245.7% +66.8% +66.2% +65.9% +69.0%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 92 -138 -139 -140 -4.6 -150.0 Nov 9, 2023 J-GAAP
Oct - Dec, 2023 47 -165 -163 -164 -5.3 -351.1 Feb 13, 2024 J-GAAP
Jan - Mar, 2024 69 -294 -294 -294 -9.5 -426.1 May 10, 2024 J-GAAP
Apr - Jun, 2024 61 -166 -161 -161 -5.1 -272.1 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 108 -103 -106 -107 -3.3 -95.4 Nov 8, 2024 J-GAAP
YoY +17.4% +25.4% +23.7% +23.6% +28.2%

Related Articles